UNH is scheduled to report its first quarter 2015 results on Thursday morning.
UnitedHealth Group is all set to report its January to March 2015 earnings on Thursday, April 16. During the fiscal year 2015, the company is expected to post revenue of over $140 billion and earnings per share of $6 to $6.25. The health care company surpassed market estimation last year, with earnings per share increasing from $5.50 in prior year to $5.70 in 2014.
The company was able to enhance its top line growth in spite of doubts regarding contrary impression from the Affordable Care Act, with combined revenue over passing $130 billion mark in a year. Company’s operating earnings got better by 7% on year over year basis and stood at $10.2 billion. The company got advantage from the outstanding growth throughout its divisions, mainly the Medicaid and Optum divisions.
Forbes expects UnitedHealth’s increased involvement in the next enrollment period on healthcare platforms, together with enhanced customer involvement, to influence the first quarter results of the company. Moreover, the Optum division is expected to remain on the success path. Forbes also estimated company’s target price of $105, which is marginally lower than the current stock price.
Analysts forecasted UnitedHealth to report earnings of $1.34 per share, which is 22% higher than the last year. Revenue is most likely to surge by 9% to $34.6 billion.
Earlier this year, UnitedHealth Group said that it believes that earnings for the current fiscal year will be around $6 to $6.5 per share, and revenue forecasted in the range of $140.5 to $141.5 billion.
On Tuesday, Credit Suisse increased the target price on the company’s stock to $135 from $120, while reiterated a rating of Buy. The improvement in price target came because of UnitedHealth’s deal to acquire Catamaran Corp for almost $13.5 billion in an attempt to surge its pharmacy benefits business and arise as a big competitor in health care industry.
Almost 25 analysts, who were polled by Bloomberg specifies that most of sell side companies are bullish in company stock. 18 analysts rated the stock as Buy with 6 assigning Hold rating. The 12-month mean price target is $131.30.
At market close on Wednesday, UNH stock was down by 2.17% to $117.32.
The company was able to enhance its top line growth in spite of doubts regarding contrary impression from the Affordable Care Act, with combined revenue over passing $130 billion mark in a year. Company’s operating earnings got better by 7% on year over year basis and stood at $10.2 billion. The company got advantage from the outstanding growth throughout its divisions, mainly the Medicaid and Optum divisions.
Forbes expects UnitedHealth’s increased involvement in the next enrollment period on healthcare platforms, together with enhanced customer involvement, to influence the first quarter results of the company. Moreover, the Optum division is expected to remain on the success path. Forbes also estimated company’s target price of $105, which is marginally lower than the current stock price.
Analysts forecasted UnitedHealth to report earnings of $1.34 per share, which is 22% higher than the last year. Revenue is most likely to surge by 9% to $34.6 billion.
Earlier this year, UnitedHealth Group said that it believes that earnings for the current fiscal year will be around $6 to $6.5 per share, and revenue forecasted in the range of $140.5 to $141.5 billion.
On Tuesday, Credit Suisse increased the target price on the company’s stock to $135 from $120, while reiterated a rating of Buy. The improvement in price target came because of UnitedHealth’s deal to acquire Catamaran Corp for almost $13.5 billion in an attempt to surge its pharmacy benefits business and arise as a big competitor in health care industry.
Almost 25 analysts, who were polled by Bloomberg specifies that most of sell side companies are bullish in company stock. 18 analysts rated the stock as Buy with 6 assigning Hold rating. The 12-month mean price target is $131.30.
At market close on Wednesday, UNH stock was down by 2.17% to $117.32.
No comments:
Post a Comment